Clinical Trials Browser

OTHER × Carcinoma, Hepatocellular × zimberelimab × Clear all

NCT05724563 2025-05-21

Domvanalimab and Zimberelimab in Advanced Liver Cancers

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma